ClinicalTrials.govpublic full text
OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ER
overactive bladder, botulinum toxin, oxybutynin, spinal cord injury, urinary incontinence, nerve growth factor, urine biomarkers, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 905953
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.